Some random links on cholesterol and diabetes. They arrived in my daily research update and I’ve found them interesting. Interesting in that most of the treatments focus on a big pharma approach when simply dietary changes will work just as well.
So without further adieu, here are the ones I found most interesting…
- Could it be they’re targeting the wrong LDL particles? After all, statin therapy doesn’t care and the lipophobes certainly don’t. But according to this study from JAMA, lowering your LDL-C doesn’t necessarily reduce your risk of MI. Go figure. They seem a bit confused and hell-bent on finding a prophylactic treatment. I’ll do a full post on this article next week.
- And yet they’re told fructose is okay in moderation. Could it be all the fructose in their diet leads to liver problems? Why not tell them to control their carbohydrate intake and eliminate fructose (HFCS, specifically – see this post)? Oh no, that wouldn’t be prudent. That doesn’t fit with our ability to prescribe medicine.
- More backpedaling on the ACCORD trial. The mess that is the ACCORD trial has been discussed by Dr. Eades. It amazes me that aggressive behavior entails more intense prophylactic treatment. Could it be the danger arose from the prophylactic cocktails? Why not? Intensive HbA1C control through diet works extremely well and there is no cocktail effect.
- Red wine is good for you? What? No Glevlivet or Anejo. I’ll take a glass or two after a long week!
So there you have it. A few research updates.
Next week I’ll do a full review of the JAMA article.
Related posts:
